These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7515418)
1. Effect of terfenadine on substance P and vasoactive intestinal polypeptide concentrations in nasal secretions from patients with nasal allergy. Takeyama M; Mori K; Morikawa N; Asakura S; Chaen T; Watanabe N; Mogi G J Pharm Pharmacol; 1994 Jan; 46(1):41-5. PubMed ID: 7515418 [TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy. Chaen T; Watanabe N; Mogi G; Mori K; Takeyama M Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):16-21. PubMed ID: 7678375 [TBL] [Abstract][Full Text] [Related]
3. Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions. Shinoda M; Watanabe N; Suko T; Mogi G; Takeyama M Am J Rhinol; 1997; 11(3):237-41. PubMed ID: 9209598 [TBL] [Abstract][Full Text] [Related]
4. Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method. Chalastras T; Nicolopoulou-Stamati P; Patsouris E; Eleftheriadou A; Kandiloros D; Yiotakis I; Gonidi M; Athanassiadou P J Laryngol Otol; 2008 Jul; 122(7):700-6. PubMed ID: 18282334 [TBL] [Abstract][Full Text] [Related]
5. Effect of terfenadine on the plasma concentrations of substance P and vasoactive intestinal polypeptide in volunteers. Mori K; Asakura S; Morikawa N; Takeyama M J Pharm Pharmacol; 1992 Oct; 44(10):856-8. PubMed ID: 1280680 [TBL] [Abstract][Full Text] [Related]
7. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608 [TBL] [Abstract][Full Text] [Related]
8. [Seasonal fluctuations of substance P and vasoactive intestinal peptide concentrations in nasal secretions of patients with nasal allergy to Japanese cedar pollen]. Mori K; Asakura S; Morikawa N; Chaen T; Watanabe N; Mogi G; Takeyama M Arerugi; 1992 Dec; 41(12):1651-7. PubMed ID: 1283939 [TBL] [Abstract][Full Text] [Related]
9. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. Kim DH; Park IH; Cho JS; Lee YM; Choi H; Lee HM Am J Rhinol Allergy; 2011; 25(1):e44-7. PubMed ID: 21711977 [TBL] [Abstract][Full Text] [Related]
10. [The investigation for the neuropeptides of nasal septum in perennial allergic rhinitis patient]. Zhu Q; Zhang S; Wu J; Tang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 23(8):339-42. PubMed ID: 19685709 [TBL] [Abstract][Full Text] [Related]
11. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Tønnesen P; Hindberg I; Schaffalitzky de Muckadell OB; Mygind N Allergy; 1988 May; 43(4):310-7. PubMed ID: 2455456 [TBL] [Abstract][Full Text] [Related]
12. Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis. Schäper C; Gustavus B; Koch B; Ewert R; Felix SB; Kunkel G; Noga O; Gläser S J Investig Allergol Clin Immunol; 2010; 20(3):214-21. PubMed ID: 20635787 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of IL-18 in allergic rhinitis. Verhaeghe B; Gevaert P; Holtappels G; Lukat KF; Lange B; Van Cauwenberge P; Bachert C Allergy; 2002 Sep; 57(9):825-30. PubMed ID: 12169180 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study on blocking agent of substance P nerves in the treatment of allergic rhinitis]. Zhang R; Jiang D; Li Z Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):282-5. PubMed ID: 7536431 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Bensch GW; Nelson HS; Borish LC Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065 [TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide levels of nasal secretions in allergic patients and control subjects. Asakura K; Enomoto K; Azuma E; Sohma S; Kataura A Arch Otorhinolaryngol; 1984; 240(3):249-53. PubMed ID: 6091600 [TBL] [Abstract][Full Text] [Related]
17. [Use of first and second generation antihistaminics in pediatric patients with allergic rhinitis]. Siu Loy R; Zebede M Rev Med Panama; 1989 Sep; 14(3):128-34. PubMed ID: 2573113 [TBL] [Abstract][Full Text] [Related]
18. The significance of nasal protease inhibitor concentrations in house dust allergy. Rudolph R; Dölling J; Kunkel G; Staud RD; Baumgarten C Allergy; 1978 Dec; 33(6):310-5. PubMed ID: 751528 [TBL] [Abstract][Full Text] [Related]
19. [Clinical observation and therapeutic mechanism of blocking agent of substance P nerves in the treatment of perennial allergic rhinitis]. Zhang R; Jiang D; Li Z Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(3):163-5. PubMed ID: 8579875 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of terfenadine, loratadine, and astemizole in perennial allergic rhinitis. Crawford WW; Klaustermeyer WB; Lee PH; Placik IM Otolaryngol Head Neck Surg; 1998 May; 118(5):668-73. PubMed ID: 9591867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]